NCT05064306 2025-08-01
131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults
Memorial Sloan Kettering Cancer Center
No longer available
Clinical Trials
11 trialsNCT05941637 2024-12-31
An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF)
Lynkcell Europe
No longer available
NCT05002465 2023-09-11
Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer
University of Texas Southwestern Medical Center
No longer available
NCT05415228 2023-05-18
Expanded Access to Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrent Prostate Cancer
University of Michigan
No longer available
NCT04854369 2023-04-11
Firefly
Tulane University
No longer available
NCT03501940 2022-01-21
F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer
Stanford University
No longer available
NCT04800068 2022-01-21
Expanded Access [Ga-68] PSMA-11 PET Imaging
Mayo Clinic
No longer available
NCT02826395 2020-07-24
C11 Sodium Acetate PET/CT Imaging of PCa
Jonsson Comprehensive Cancer Center
No longer available
NCT03386071 2019-01-16
Compassionate Use: Progressive Metastatic Castrate Resistant Prostate Cancer; Monotherapy Treatment With Trametinib
Jonsson Comprehensive Cancer Center
No longer available
NCT01777061 2018-05-16
Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan
University of Kansas Medical Center
No longer available
NCT03005262 2018-04-04
MLN8237 for a Subject With Adenocarcinoma of the Prostate
The University of Texas Health Science Center at San Antonio
No longer available